Page images
PDF
EPUB

(5) Facilities for vaccination against cholera, yellow fever, and smallpox.

§ 71.605 Yellow fever areas: Sanitary requirements: Ports and airports.

(a) Every port, and the area within the perimeter of every airport, shall be kept free from Aedes aegypti in its larval and adult stages.

(b) Any building within a direct transit area provided at any airport situated in a yellow fever receptive area shall be mosquito proof.

(c) Every person employed at an airport situated in a local area infected with yellow fever and every member of the crew of an aircraft using any such airport shall be in possession of a valid certificate of vaccination against yellow fever.

(d) Every sanitary airport situated in a yellow fever receptive area shall:

(1) Be provided with mosquito-proof dwellings and have at its disposal mosquito-proof sick quarters for passengers, crews and airport personnel; and

(2) Be freed from mosquitoes by systematically destroying them in their larval and adult stages within the perimeter of the airport, and within a protective area extending for a distance of four hundred meters around that perimeter.

[21 FR 9870, Dec. 12, 1956, as amended at 22 FR 6464, Aug. 13, 1957]

§ 71.606 Perimeter: Airports only.

As used in this subpart, the perimeter of an airport means a line enclosing the airport buildings and any land or water used or intended to be used for the parking of aircraft.

§ 71.607 Withdrawal of designation.

The designation of an airport as a sanitary airport may be withdrawn by the Surgeon General after reasonable notice to the airport whenever he finds that the airport fails to comply with any applicable sanitary requirement prescribed in this subpart or fails to meet the conditions prescribed in §§ 71.602 and 71.603.

§ 71.608 Cholera and plague: Persons unloading vessels or aircraft.

(a) Cholera. Persons who unload a cholera infected vessel or aircraft, and

in the judgment of the medical officer in charge have been exposed to risk of infection, shall be placed under surveillance for a period not to exceed five days from the time they cease unloading.

(b) Plague. Persons who unload a vessel or aircraft may be disinsected and placed under surveillance or in isolation for a period not to exceed six days from the time they cease unloading, if the vessel or aircraft is infected or during the voyage has been infected with human or rodent plague, or if inspection of the vessel or aircraft has revealed rodent mortality of undetermined cause, and in the judgment of the medical officer in charge such persons have been exposed to risk of infection.

§ 71.609 Designation of international airports.

(a) International airports (see § 71.501(b)) will be designated after due investigation to establish the fact that a sufficient need exists in any particular district or area to justify such designation and to determine the airport best suited for such purpose.

(b) A specific airport will be designated in each case, rather than a general area or district which may include several airports.

(c) The designation as an international airport may be withdrawn if it is found that the volume of business clearing through the port does not justify maintenance of inspection equipment and personnel, if proper facilities are not provided and maintained by the airport, if the rules and regulations of the Federal Government are not complied with, or if it be found that some other location would be more advantageous.

(d) International airports shall be municipal airports, unless particular conditions which prevail warrant a departure from this requirement.

(e) Each international airport shall provide without cost to the Government suitable office and other space for the exclusive use of Federal officials connected with the port. A suitable surfaced loading area shall be provided by each airport at a convenient location with respect to such

office space. Such loading area shall be reserved for the use of aircraft entering or clearing through the airport.

(f) International airports shall be open to all aircraft for entry and clearance purposes and no charge shall be made for the use of said airports for such purposes. However, in any case where an international airport authorizes any such aircraft to use such airport for the taking on or discharging of passengers or cargo, or as a base for other commercial operations or for private operations, this paragraph shall not be interpreted to mean that charges may not be made for such commercial or private use of such airport.

(g) All aircraft entering or clearing through an international airport shall receive the required servicing by airport personnel promptly and in the order of arrival or preparation for departure without discrimination. The charges made for such servicing shall in no case exceed the schedule of charges prevailing at the airport in question. A copy of said schedule of charges shall be posted in a conspicuous place at the office space provided for the use of Federal officials connected with the port.

(h) International airports shall adopt and enforce observance of such requirements for the operation of airports, including airport rules, as may be prescribed or recommended by the Federal Aviation Agency.

(i) Requirements in addition to all the foregoing may be imposed at a particular airport as the needs of the district or area to be served by the airport may demand.

§ 71.700 Appendix-Excerpts from International Sanitary Regulations (World Health Organization Regulations No. 2).

PART I-DEFINITIONS
Article 1

For the purposes of these Regulations

"direct transit area" means a special area established in connexion with an airport, approved by the health authority concerned and under its direct supervision, for accommodating direct transit traffic and, in par

ticular, for accommodating, in segregation, passengers and crews breaking their air voyage without leaving the airport;

"local area" means

(a) The smallest area within a territory. which may be a port or an airport, having a defined boundary and possessing a health organization which is able to apply the appropriate sanitary measures permitted or prescribed by these Regulations; the situation of such an area within a larger area which also possesses such a health organization shall not preclude the smaller area from being a local area for the purposes of these Regulations; or (b) an airport in connexion with which a direct transit area has been established;

PART IV-SANITARY MEASURES AND

PROCEDURES

CHAPTER II-SANITARY MEASURES ON DEPARTURE

Article 30

1. The health authority for a port or an airport or for the local area in which a frontier post is situated may, when it considers it necessary, medically examine any person before his departure on an international voyage. The time and place of this examination shall be arranged to take into account the customs examination and other formalities, so as to facilitate his departure and to avoid delay.

2. The health authority referred to in paragraph 1 of this Article shall take all practicable measures

(a) To prevent the departure of any infected person or suspect;

(b) To prevent the introduction on board a ship, an aircraft, a train, or a road vehicle of possible agents of infection or vectors of a quarantinable disease.

3. Notwithstanding the provisions of subparagraph (a) of paragraph 2 of this Article, a person on an international voyage who on arrival is placed under surveillance may be allowed to continue his voyage. If he is doing so by air, the health authority for the airport shall record the fact on the General Declaration.

PART VI-SANITARY DOCUMENTS

Article 98

1. The certificates specified in Appendices 1, 2, 3, and 4 shall be printed in English and in French. An official language of the territory of issue may be added.

2. The certificates referred to in paragraph 1 of this Article shall be completed in English or in French.

Article 99

A vaccination document issued by the Armed Forces to an active member of those Forces shall be accepted in lieu of an international certificate in the form shown in Appendix 2, 3, or 4 if

(a) It embodies medical information substantially the same as that required by such form; and

(b) It contains a statement in English or in French recording the nature and date of the vaccination and to the effect that it is issued in accordance with this Article.

PART X-TRANSITIONAL PROVISIONS

Article 115

1. A certificate of vaccination issued in accordance with the Convention of 21 June 1926, as amended by the Convention of 15 December 1944, or in accordance with the Convention of 12 April 1933, as amended by the Convention of 15 December 1944, before the entry-into-force of these Regulations shall continue to be valid for the period for which it was previously valid. Moreover, the validity of a certificate of vaccination against yellow fever so issued shall be extended for two years after the date on which it would otherwise have ceased to be valid.

NOTE: Forms relating to International Sanitary Regulations filed as part of the original document.

[blocks in formation]

§ 72.1

Definitions.

As used in this part:

"Biological product" means a biological product prepared and manufactured in accordance with the provisions of 9 CFR Parts 102-104 and 21 CFR Parts 312 and 600-680 and which, in accordance with such provisions, may be shipped in interstate traffic.

"Diagnostic specimen" means any human or animal material including, but not limited to, excreta, secreta, blood and its components, tissue, and tissue fluids being shipped for purposes of diagnosis.

"Etiologic agent" means a viable microorganism or its toxin which causes, or may cause, human disease.

"Interstate traffic" means the movement of any conveyance or the transportation of persons or property, including any portion of such movement or transportation which is entirely within a State or possession, (a) from a point of origin in any State or possession to a point of destination in any other State or possession, or (b) between a point of origin and a point of destination in the same State or possession but through any other State, possession, or contiguous foreign country.

'The requirements of this part are in addition to and not in lieu of any other packaging or other requirements for the transportation of etiologic agents in interstate traffic prescribed by the Department of Transportation and other agencies of the Federal Government.

§ 72.2 Transportation of diagnostic specimens, biological products, and other materials; minimum packaging requirements.

No person may knowingly transport or cause to be transported in interstate traffic, directly or indirectly, any material including, but not limited to, diagnostic specimens and biological products which such person reasonably believes may contain an etiologic agent unless such material is packaged to withstand leakage of contents, shocks, pressure changes, and other conditions incident to ordinary handling in transportation.

§ 72.3 Transportation of materials containing certain etiologic agents; minimum packaging requirements. Notwithstanding the provisions of § 72.2, no person may knowingly transport or cause to be transported in interstate traffic, directly or indirectly, any material (other than biological products) known to contain, or reasonably believed by such person to contain, one or more of the following etiologic agents unless such material is packaged, labeled, and shipped in accordance with the requirements specified in paragraphs (a) through (f) of this section:

[blocks in formation]

Klebsiella-all species and all serotypes. Legionella-all species and all Legionellalike organisms.

Leptospira interrogans—all serovars.
Listeria-all species.
Mimae polymorpha.
Moraxella-all species.
Mycobacterium-all species.
Mycoplasma-all species.

Neisseria gonorrhoeae, N. meningitidis.
Nocardia asteroides.
Pasteurella-all species.
Plesiomonas shigelloides.
Proteus-all species.
Pseudomonas mallei.

Pseudomonas pseudomallei.

Salmonella-all species and all serotypes.
Shigella-all species and all serotypes.
Sphaerophorus necrophorus.
Staphylococcus aureus.
Streptobacillus moniliformis.
Streptococcus pneumoniae.
Streptococcus pyogenes.

Treponema careteum, T. pallidum, and T. pertenue.

Vibrio cholerae, V. parahemolyticus. Yersinia (Pasteurella) pestis, Y. enterocolitica.

FUNGAL AGENTS

Blastomyces dermatitidis.
Coccidioides immitis.
Cryptococcus neoformans.
Histoplasma capsulatum.
Paracoccidioides brasiliensis.

VIRAL AND RICKETTSIAL AGENTS Adenoviruses-human-all types.

Arboviruses-all types.

Coxiella burnetii.

Coxsackie A and B viruses-all types. Creutzfeldt-Jacob agent

Cytomegaloviruses.

Dengue viruses-all types.

Ebola virus.

Echoviruses-all types.

Encephalomyocarditis virus.

Hemorrhagic fever agents including, but not limited to, Crimean hemorrhagic fever (Congo), Junin, Machupo viruses, and Korean hemorrhagic fever viruses.

Hepatitis associated materials (hepatitis A, hepatitis B, hepatitis nonA-nonB). Herpesvirus-all members.

Infectious bronchitis-like virus.
Influenza viruses-all types.
Kuru agent.
Lassa virus.

Lymphocytic choriomeningitis virus.

Marburg virus.

Measles virus.

Mumps virus.

Parainfluenza viruses-all types.

Polioviruses-all types.

Poxviruses-all members.

Rabies virus-all strains.
Reoviruses-all types.
Respiratory syncytial virus.
Rhinoviruses-all types.

Rickettsia-all species.
Rochalimaea quintana.
Rotaviruses-all types.
Rubella virus.

Simian virus 40.

Tick-borne encephalitis virus complex, including Russian spring-summer encephalitis, Kyasanur forest disease, Omsk hemorrhagic fever, and Central European encephalitis viruses.

Vaccinia virus.

Varicella virus.

Variola major and Variola minor viruses.
Vesicular stomatis viruses-all types.
White pox viruses.
Yellow fever virus.2

(a) Volume not exceeding 50 ml. Material shall be placed in a securely closed, watertight container (primary container (test tube, vial, etc.)) which shall be enclosed in a second, durable watertight container (secondary container). Several primary containers may be enclosed in a single secondary container, if the total volume of all the primary containers so enclosed does not exceed 50 ml. The space at the top, bottom, and sides between the primary and secondary containers shall contain sufficient nonparticulate absorbent material (e.g., paper towel) to absorb the entire contents of the primary container(s) in case of breakage or leakage. Each set of primary and secondary containers shall then be enclosed in an outer shipping con

tainer constructed of corrugated fiberboard, cardboard, wood, or other material of equivalent strength.

(b) Volume greater than 50 ml. Packaging of material in volumes of 50 ml. or more shall comply with requirements specified in paragraph (a) of this section. In addition, a shock absorbent material, in volume at least equal to that of the absorbent material between the primary and secondary containers, shall be placed at the top, bottom, and sides between the secondary container and the outer shipping container. Single primary containers shall not contain more than 1,000 ml of material. However, two or more primary containers whose combined volumes do not exceed 1,000 ml may be placed in a single, secondary container. The maximum amount of etiologic agent which may be enclosed within a single outer shipping container shall not exceed 4,000 ml.

(c) Dry ice. If dry ice is used as a refrigerant, it must be placed outside the secondary container(s). If dry ice is used between the secondary container and the outer shipping container, the shock absorbent material shall be placed so that the secondary container does not become loose inside the outer shipping container as the dry ice sublimates.

(d)(1) The outer shipping container of all materials containing etiologic agents transported in interstate traffic must bear a label as illustrated and described below:

« PreviousContinue »